Risk factors of acute myocardial infarction following primary percutaneous coronary intervention among elderly patients

( views:, downloads: )
Fangming Guo(Department of Cardiology, the 2nd Hospital of Tianjin Medical University, Tianjin 300021, P.R.China)
Xiaohuan Wang(Department of Cardiology, the 2nd Hospital of Tianjin Medical University, Tianjin 300021, P.R.China)
Guangping Li(Department of Cardiology, the 2nd Hospital of Tianjin Medical University, Tianjin 300021, P.R.China)
Xin Chen(Department of Cardiology, the 2nd Hospital of Tianjin Medical University, Tianjin 300021, P.R.China)
Yuguang Jin(Department of Cardiology, Yantai Hill Hospital, Yantai Shandong 264001, P.R. China)
Journal Title:
Volume 6, Issue 02, 2009
Key Word:
Acute myocardial infarction;percutaneous coronary intervention;elderly

Abstract: Background and Objective Large randomized controlled trials have demonstrated that percutaneous coronary intervention (PCI) with the routine use ofdrug-eluting stents is safe and effective, however, the patients older than 75 years undergoing PCI are at increased risk for major adverse cardiac events, so that the patients are usually excluded from this trial. The aim of the present study was to assess the early clinical outcome and risk factors in old patients with acute ST elevation myocardial infarction (STEMI) following primary PCI. Methods We analyzed the outcome after stenting in 136 patients older than 60 years in our coronary care unit with acute STEMI, and the patients were further classified in 2 age groups: patients≥75 years and <75 years. Results Though the older group had a higher prevalence of adverse baseline characteristics and lower final TIMI flow than those of the younger, the procedural success had no difference between two groups. The main adverse clinical events (MACE) for the old group was a little higher comparing with the younger in 12-month following up. Conclusions Our study suggest that drug-eluting stent implantation in elderly patients with acute ST elevation myocardial infarction has high initial procedural success rates despite having more severe baseline risk characteristics, and to shorten the time form symptom onset to PC1 and improve final TIMI flow strategy may decrease MACE among old patients following PCI.

  • [1]Abizaid AS,Mintz GS,Abizaid A,et al.Influence of patient age on acute and late clinical outcomes following PalmazSchatz coronary stent implantation.Am J Cardiol 2000; 85:338-43.
  • [2]Kobayashi Y,Mehran R,Mintz GS,et al.Comparison of inhospital and one-year outcomes after multiple coronary arterial stenting in patients ≥ 80 years old versus those 《80 years old.J Am Coil Cardiol 2003;92:443-6.
  • [3]Pfisterer M,Buser P,Osswald S,et al.Trial of lnvasive versus Medical therapy in Elderly patients (TIME) Investigators.Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs.optimized medical treatment strategy:one-year results of the randomized TIME trail.JAMA 2003;289:1117-23.
  • [4]Guagliumi G,Stone GW,Cox DA,et al.Outcome in elderly patients" undergoing primary coronary intervention for acute myocardial infarction:results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.Circulation 2004; 110:1598-604.
  • [5]Hassani SE,Wolfram RM,Kuehulakanti PK,et al.Percutaneous coronary intervention with drug-eluting stents in octogenarians:characteristics,clinical presentation,and outcomes.Catheter Cardiovasc lnterv 2006; 68:36-43.
  • [6]Yoshida T,Kawano H,Miyamoto S,et al.Prognostic value of flow-mediated dilation of the brachial artery in patients with cardiovascular disease.Intern Med 2006;45:575-9.
  • [7]Brevetti G,Silvestro A,Sehiano V,et al.Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease:additive value of flow-mediated dilation to anklebrachial pressure index.Circulation 2003;108:2093-8.
  • [8]Mangoni AA,Jackson SH.The implications of a growing evidence base for drug use in elderly patients.Part 3.Betaadrenoceptor blockers in heart failure and thrombolytics in acute myocardial infarction.Br J Clin Pharmacol 2006; 61(5):513-20.
  • [9]Labriolle A,Giraudeau B,Pacouret G T,et al.Revascularization algorithm in acute STEMI should take into account age.Cardiovasc Revase Med 2007; 8(2):90-3.
  • [10]Holmes DR Jr,White HD,Pieper KS,et al.Effect of age on outcome with primary angioplasty versus thrombolysis.J Am Coil Cardiol 1999; 33:412-9.
  • [11]Maynard C,Every NR.Thrombolysis versus primary angioplasty in older patients with acute myocardial infaretion.Drugs Aging 1999; 14(6):427-35.
  • [12]Cannon CP,MeCabe CH,Diver DJ,et al.Comparison of frontloaded recombinant tissue-type plasminogen activator,anistreplase and combination thrombolytic therapy for acute myocardial infarction:results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.J Am Coil Cardiol 1994; 24:1602-10.
  • [13]Gibson CM,Murphy SA,Morrow DA,et al.Angiographic perfusion score:an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction.Am Heart J 2004; 148:336-40.
  • [14]Thompson RC,Holmes DR,Grill DE,et al.Changing outcome of angioplasty in the elderly.J Am Coil Cardiol 1996; 27:8-14.
  • [15]Santana JO,Haft JI,Larmache NS,et al.Coronary angioplasty in patients eighty years of age or older.Am Heart J 1992;40:190-22.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn